XML 19 R8.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Cash flows from operating activities:        
Net income $ 3,407 $ 799 $ 4,500 $ 425
Adjustments to reconcile net income to cash flow from operating activities:        
Depreciation and amortization 16,763 15,231 33,315 30,059
Amortization of deferred financing costs     738 723
Stock compensation     4,646 3,859
Casualty losses 0 411 359 411
Amortization related to derivative instruments     608 579
Changes in assets and liabilities:        
Other assets     (4,886) (4,348)
Accounts payable and accrued expenses     3,985 2,812
Accrued interest payable     (67) (188)
Other liabilities     54 7
Cash flow provided by operating activities     43,252 34,339
Cash flows from investing activities:        
Acquisition of real estate properties     (139,231) (50,618)
Investments in unconsolidated real estate entities     (10,205)  
Capital expenditures     (17,244) (17,070)
Cash flow used in investing activities     (166,680) (67,688)
Cash flows from financing activities:        
Proceeds from unsecured credit facility and term loans     369,500 65,501
Unsecured credit facility repayments     (234,800) (39,000)
Mortgage principal repayments     (23,456) (3,835)
Payments for deferred financing costs     (1,205) (50)
Proceeds from issuance of common stock, net     41,551 49,732
Distributions on common stock     (24,666) (33,479)
Distributions to noncontrolling interests     (162) (302)
Repurchase of shares related to equity award tax withholding     (2,942) (1,490)
Cash flow provided by financing activities     123,820 37,077
Net change in cash and cash equivalents, and restricted cash     392 3,728
Cash and cash equivalents, and restricted cash, beginning of period     13,615 14,433
Cash and cash equivalents, and restricted cash, end of the period 14,007 18,161 14,007 18,161
Reconciliation of cash, cash equivalents, and restricted cash to the Consolidated Balance Sheet        
Cash and cash equivalents 7,566 11,652 7,566 11,652
Restricted cash 6,441 6,509 6,441 6,509
Cash and cash equivalents, and restricted cash, end of the period $ 14,007 $ 18,161 $ 14,007 $ 18,161